Epirium

📍 San Diego, United States🗓 Founded 2008👥 17 employees💰 Last funded Dec 2019
Pharmaceutical Manufacturing🌐 epirium.com
Website LinkedIn
Epirium is a clinical-stage biopharmaceutical company that has developed unique insights related to the biology of mitochondrial biogenesis and tissue function, potentially resulting in novel therapeutic approaches to currently intractable neuromuscular diseases. The company has identified and established an IP-protected platform of small molecules that constitute a new class of therapeutics with the potential to stimulate mitochondrial biogenesis and tissue regeneration. Epirium is currently planning clinical trials with its initial drug candidate in Becker muscular dystrophy. To learn more, please visit http://www.epirium.com/. Headed by a seasoned team of industry veterans with decades of experience building and leading clinical and commercial stage companies, Epirium is committed to advancing and bringing to market life-saving therapies through novel and uncharted pharmacological approaches. We are looking for passionate and collaborative individuals to join our team in an exciting biopharmaceutical environment. If you are looking for a meaningful position that could transform the lives of patients, this is the opportunity you have been waiting for.
1
Total investors
0
Early stage
0
Mid stage
0
Late stage
2008
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
1
Frequently asked questions
Who invested in Epirium?
Epirium has 1 investors on record on gritt.io.
When did Epirium last raise funding?
The most recent investment in Epirium recorded on gritt.io was in December 2019.
When was Epirium founded?
Epirium was founded in 2008.
What industry is Epirium in?
Epirium operates in Pharmaceutical Manufacturing. Find similar Pharmaceutical Manufacturing investors on gritt.io.
Where is Epirium based?
Epirium is headquartered in San Diego, United States.